Joanne Lagmay, MD - Research

Research at a glance

Top areas of exploration

Biomarkers, Tumor , 6 publications
Bone Neoplasms , 5 publications
Neoplasm Recurrence, Local , 5 publications
Osteosarcoma , 4 publications

Research activity

28 publications

441 citations

Why is this important?

Active clinical trials

Neuroblastoma Maintenance Therapy Trial (NMTT)

Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 卤鈥�

Investigator: Joanne Lagmay
Status: Accepting Candidates
Ages: 1 Year - 30 Years
Sexes: All

My publications

28 publications

2025

"Somewhat of an Adult": Understanding the "Dance" of Competing Tensions Parents Manage While Caring for an Adolescent or Young Adult (AYA) Diagnosed with Hematologic Malignancy.

Cancers

鈥�

2025

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries.

Cancer

鈥�

2024

Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.

Cancer journal (Sudbury, Mass.)

鈥�

2024

Investigating surface proteins and antibody combinations for detecting circulating tumor cells of various sarcomas.

Scientific reports

鈥�

2024

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

Clinical cancer research : an official journal of the American Association for Cancer Research

鈥�

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

"Somewhat of an Adult": Understanding the "Dance" of Competing Tensions Parents Manage While Caring for an Adolescent or Young Adult (AYA) Diagnosed with Hematologic Malignancy.

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries.

Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.

Investigating surface proteins and antibody combinations for detecting circulating tumor cells of various sarcomas.

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.